Next Article in Journal / Special Issue
Effectiveness of the Human Oral Microbe Identification Microarray in Identifying Periodontal Pathogens: A Systematic Review
Previous Article in Journal
SARS-CoV-2 Viroporins: A Multi-Omics Insight from Nucleotides to Amino Acids
Previous Article in Special Issue
Cambisol Mycobiome in a Long-Term Field Experiment with Korean Pine as a Sole Edificator: A Case Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Recurrent Acute Otitis Media Environmental Risk Factors: A Literature Review from the Microbiota Point of View

1
Università degli Studi di Milano, 20122 Milan, Italy
2
Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
3
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy
4
Pediatria Alta Intensità di Cura, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
5
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy
*
Author to whom correspondence should be addressed.
Appl. Microbiol. 2022, 2(3), 594-613; https://doi.org/10.3390/applmicrobiol2030046
Submission received: 30 June 2022 / Revised: 6 August 2022 / Accepted: 12 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue Microbiome in Ecosystem)

Abstract

:
Acute otitis media (AOM) constitutes a multifactorial disease, as several host and environmental factors contribute to its occurrence. Prevention of AOM represents one of the most important goals in pediatrics, both in developing countries, in which complications, mortality, and deafness remain possible consequences of the disease, compared to in developed countries, in which this condition has an important burden in terms of medical, social, and economical implications. The strategies for AOM prevention are based on reducing the burden of risk factors, through the application of behavioral, environmental, and therapeutic interventions. The introduction of culture-independent techniques has allowed high-throughput investigation of entire bacterial communities, providing novel insights into the pathogenesis of middle ear diseases through the identification of potential protective bacteria. The upper respiratory tract (URT) is a pivotal region in AOM pathogenesis, as it could act as a source of pathogens than of protective microorganisms for the middle ear (ME). Due to its direct connection with the external ambient, the URT is particularly exposed to the influence of environmental agents. The aim of this review was to evaluate AOM environmental risk factors and their impact on URT microbial communities, and to investigate AOM pathogenesis from the microbiota perspective.

1. Introduction

Acute otitis media (AOM) is the most common bacterial infection and the leading cause of antibiotic prescription in childhood [1,2]. It is defined as the presence of fluid in the middle ear (ME) with signs/symptoms of acute infection [3]. Recurrent acute otitis media (RAOM), defined as the occurrence of three AOM episodes in 6 months or four AOM episodes in 12 months [4,5], implicates a great effort in assistance considering the burden of medical visits, drug prescription, and the loss of working days for parents.
The etiological agents of AOM, defined as otopathogens, comprehend Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes [6]. The upper respiratory tract (URT) represents a pivotal region in the pathogenesis of the disease. These microorganisms usually colonize the URT during infancy and constitute part of the normal nasopharyngeal flora; according to the Pathogen Reservoir Hypothesis (PRH), the URT and the adenoid pad serve as a source of pathogens that become more virulent whereas favorable circumstances impair the homeostasis established among bacteria, viruses and the host immune system [7,8,9,10], further spreading to the middle ear and respiratory system [11,12,13,14].
In recent years, the introduction of next-generation sequencing (NGS) techniques has allowed high-throughput analysis of entire bacterial communities, with a subsequent modification of our approach to investigation and management of infectious diseases, now studied under an ecological perspective: health and disease are determined by a complex balance among pathogens, host immune response and resident microbiota, not by the sole presence or absence of a pathogen [15].
The human microbiota comprehends communities of commensal, symbiotic and pathogenic microorganisms that colonize different body sites, such as the gastrointestinal tract, respiratory system, oral cavity, skin, and female reproductive system [16]. These microorganisms and their metabolites fulfill a significant role in defense against pathogens [17], immune response, and inflammation [18].
In the last decade, most of the studies on microbiota in the URT have focused on the identification of potential keystone species, that is “species that are typically not highly abundant but are disproportionately important in maintaining the organization and structure of an entire community” [19]; in particular, in the URT, Dolosigranulum spp. and Corynebacterium spp. have been identified as potential keystone species and have been related to respiratory health and exclusion of otopathogens [20,21,22,23].
The microbial communities and their composition are extremely dynamic and change under the effect of several external agents, especially in infancy and early childhood [24,25]. An impairment in the composition and consequently in the homeostatic function of the microbiota mediated by these environmental factors leads to a condition, defined as dysbiosis, which can result in immediate or long-term effects on the health status [26].
AOM is a multifactorial disease, as diverse agents contribute to its occurrence [27]. Risk factors can be distinguished into two categories: host and environmental. The first group includes age, sex, ethnicity, family history of AOM and genetic predisposition, craniofacial anomalies, atopy, immunodeficiency, adenoid hypertrophy, gastroesophageal reflux [27]; environmental factors include day-care attendance, passive smoking, older siblings, use of pacifier, no breastfeeding [27], pollution [28], season [29], delivery route [30]. Prevention of AOM represents one of the most important goals in pediatrics, both in developing countries, in which complications, mortality, and deafness remain possible consequences of the disease, than in developed ones, in which this condition has an important burden in terms of medical, social and economical implications [31,32]. The strategies put into practice for AOM prevention are mostly based on reducing the burden of risk factors while improving protective ones, through the application of behavioral, environmental, and therapeutic interventions.
The URT and its microbiota are especially exposed to environmental factors, as this region represents the interface between the external environment and the respiratory system and is interconnected with the middle ear, lower airways, and gastrointestinal tract. The most important AOM environmental risk factors likely intervene in AOM pathogenesis through the induction of major modifications and shaping of the URT microbiota. A deepened understanding of the most important characteristics of the URT microbiota and of the influence of the external conditions on its balance could provide major insights into producing probiotic therapies and improving our preventive programs.
The aim of this review is to evaluate AOM environmental risk factors and their role in the pathogenesis of the disease from the microbiota point of view through the analysis of evidence available in microbiome research on this topic.

2. Materials and Methods

The research was conducted on the PubMed database, including all evidence available until December 2021. MeSH terms such as “otitis media”, “microbiota”, “child”, “child, preschool” and “infant” were used. More articles were included combining the keywords “microbiota” and “microbiome” with terms such as “acute otitis media”, “risk factors”, and “nasopharyngeal”.
After the exclusion of duplicates, 103 potentially relevant studies were identified through this search strategy. After title-abstract analysis, 71 studies were excluded as nonpertinent, according to the following criteria: studies not coherent with the aim of this review; site of investigation different than URT; studies not evaluating risk factors for OM. Of the remaining 32 articles, 16 were further excluded as review/editorial articles, adult population, and studies conducted with culture-dependent techniques. A total of 16 articles were therefore considered for this review (see Figure 1 for more details on methods).

3. Environmental Risk Factors of AOM and URT Microbiota

3.1. Breastfeeding

Breastfeeding is a well-known protective factor against infection [33,34] and is tightly connected to the prevention of AOM recurrences [35,36]. In particular, exclusive breastfeeding and a longer duration of this practice are associated with a lower risk of AOM [37]; in a meta-analysis by Bowatte et al., exclusive breastfeeding during the first 6 months was associated with a 43% reduction in ever having AOM in the first 2 years of life [38].
This protective effect is surely related to the high amount of antibacterial substances in maternal milk [39]. Nevertheless, in the last decade evidence has enhanced the role of breastfeeding and its major impact on the development of healthy microbial communities.
Biesbroek et al. analyzed nasopharyngeal microbiota in 101 healthy breastfed infants and 101 formula-fed infants at the ages of 6 weeks and 6 months: data showed a bacterial community enriched in common commensals, in particular Dolosigranulum and Corynebacterium, in those who were breastfed at 6 weeks of age; moreover, Dolosigranulum abundance was related to a lower number of respiratory tract infections in the following months. At 6 months, no clear differences were observed in microbial profiles: the authors stated that the introduction of solid foods could reduce the dissimilarities in microbiota composition in the two groups. However, the early microbiota composition, especially an enrichment in Dolosigranulum, and its relation to breastfeeding, seemed to have an impact on respiratory health in later stages of life [40]. Another study by the same group confirmed the association between Corynebacterium/Dolosigranulum and Moraxella dominated profiles in early life to breastfeeding; moreover, these profiles appeared more stable over time and were associated with a reduced number of respiratory infections [41]. Similar results were provided by Bosch et al., in a study evaluating the potential environmental drivers of respiratory microbiota maturation. The authors identified features of nasopharyngeal microbiota in the first month of life that related to a higher number of respiratory infections: in particular, profiles characterized by a prolonged reduction of Dolosigranulum and Corynebacterium were associated with a higher number of infectious recurrencies. Vaginal delivery and breastfeeding were two important determinants of this composition, as a major abundance of these genera was observed in breastfed infants. However, analogously to previous studies, these dissimilarities were transient and disappeared around 6 months of age [42].
The relation between breastfeeding and Dolosigranulum enriched communities was further confirmed in another investigation evaluating URT microbiota in children with invasive pneumococcal disease (IPD); a higher abundance of Dolosigranulum was not only related to breastfeeding, but also had a negative correlation with S. pneumoniae abundance [43].
Concerning Corynebacterium spp., interesting data were provided in a more recent study describing the nasopharyngeal microbial communities and environmental factors that potentially shape their composition in the first year of life. Even in this case, higher abundances of Corynebacterium spp. were associated with a lower risk of S. pneumoniae colonization; feeding practices were one of the major drivers shaping the composition of microbial communities. In particular, breastfeeding was associated with an enrichment in Corynebacterium [44]. URT microbiota in IPD was also evaluated in a study by Henares et al., in which different respiratory health statuses were evaluated comparing three groups of children: 27 patients with IPD, 48 with upper respiratory tract infection (URTI), and 65 asymptomatic controls. Interestingly, microbiota composition varied with disease severity, as the IPD group was characterized by a higher representation of S. pneumoniae and a reduced abundance of Dolosigranulum. Among the environmental factors considered, a longer duration of breastfeeding seemed to influence the microbiota structure, even if the authors were not able to evidence a significant enrichment in beneficial bacteria in children breastfed for at least 6 months [45].
The potential mechanisms through which breast milk can shape the URT microbiota have been evaluated by Binia et al. in a complex and interesting study characterizing nasopharyngeal microbiome by shotgun metagenomics: mother-infant dyads in which children were breastfed for at least 4 months were selected, for a total of 240 infants included; mothers were further classified according to their secretory status by sequencing of FUT2 and FUT3 genes, which shape fucosylated human milk oligosaccharides (HMOs) in breast milk. HMOs are retained to be one of the key components of human milk in determining its protective action against infections [46,47]. A positive maternal secretor status was associated with a lower risk of acute respiratory infections in the first 6 months of life, suggesting a protective role of 1, 2-fucosylated HMOs in early infancy. However, the authors could not find evidence that this protective effect of HMOs is conveyed by the modulation of microbiota and could not relate its composition at 2 and 4 months to a subsequent acute respiratory infection (ARI) risk. The authors thus concluded that breastfeeding and HMOs could act through an immunomodulatory effect, rather than through a direct impact on microbiota composition [48]. Therefore, the higher abundance of Corynebacterium and Dolosigranulum does not appear to be related to the presence of HMOs in human milk. To date, the enrichment with these two genera in breastfed infants is more likely related to the composition of the human milk itself rather than to its metabolic effects. For instance, Corynebacterium spp. have been frequently isolated from human milk [49,50,51], while clear data are lacking concerning Dolosigranulum, even if its presence has been also described in human mature milk [52]. Moreover, Corynebacterium spp. are known common colonizers of the human skin [53], so it is likely that its enrichment in breastfed infants is supported by the close contact of the infants’ respiratory tract with the maternal skin during breastfeeding. Notably, it is also plausible that the enrichment in Dolosigranulum in breastfed infants is mediated indirectly through Corynebacterium spp. It is indeed well-known that these two microorganisms are often found to be co-occurrent in the URT, and in vitro assays have shown that certain nasal Corynebacterium spp. can enhance the growth of Dolosigranulum [54].

3.2. Delivery Route

Vaginal delivery represents another significant protective factor against infections. Children born by caesarian section (CS) experience a higher number of subsequent respiratory recurrences in comparison with children born by vaginal delivery [55,56]. AOM is clearly included among this group of infections: evidence shows a highly significant increased risk for >3 episodes of OM in children born by CS [30]. Moreover, a more recent retrospective study on a high sample size conducted in Canada and including 36.318 children showed that CS delivery is associated with a slightly higher risk of OM and a higher number of OM episodes [57].
One of the potential mechanisms explaining the association between CS and infection is related to the alterations in innate and adaptative immunity described in children born by CS [58]. However, one of the most interesting aspects concerns the different microbial colonization patterns in different body sites in relation to the delivery route. At birth, the majority of the microorganisms encountered by the newborn are provided by the mother’s vaginal environment through the passage in the birth canal [56]. This initial colonization step, irretrievably connected to the delivery route, is crucial in defining the subsequent ecosystems and their development trajectories, therefore influencing the health status in the following years [59]. Concerning nasopharyngeal microbiota, the first bacterial communities after birth were initially described by Dominguez-Bello et al., in a study in which swabs were collected from different body sites from healthy neonates born vaginally or by CS immediately after birth: in the first phases of life, undifferentiated microbial communities were identified; interestingly, these communities resembled vaginal microbiota in children vaginally delivered, while they were more similar to maternal skin microbiota in those who were born by CS. For instance, microbiota in vaginally delivered children was enriched in Lactobacillus, Prevotella, Atopobium, or Sneathia spp., while children born by CS had communities enriched in skin commensals, as Staphylococcus spp. [60].
A subsequent prospective cohort study evaluated the nasopharyngeal microbiome in 102 children through their first 6 months of life, providing interesting insights on the developmental patterns of URT microbiota in relation to the delivery route. Data show that a nasopharyngeal niche differentiation occurs at one week of age, characterized by a higher abundance of S. aureus in almost all children; a subsequent reduction of S. aureus is replaced by Corynebacterium spp. and Dolosigranulum spp., followed by Moraxella catarrhalis/nonliquefaciens, S. pneumoniae, and H. influenzae in the first six months. Mode of delivery had a major influence on this process, as children born by vaginal delivery used to switch to Moraxella and Corynebacterium/Dolosigranulum dominated profiles at an earlier age compared to those born by CS; on the other hand, CS born children were longer colonized by S. aureus enriched communities. Moreover, not only vaginally delivered children were more likely to switch to Corynebacterium/Dolosigranulum dominated profiles, but communities of infants born by CS had a lower abundance of these potential protective bacteria [59].
The mechanisms underlying the correlation between delivery route and URT microbiota composition are not clearly defined. Dolosigranulum pigrum is included in the group of Lactic Acid Bacteria (LAB), which also encompasses Lactobacillus spp.; these microorganisms are fundamental members of the vaginal microbiota, and especially the production of lactic acid has been associated with a healthy genital environment [61]. However, a recent study evaluated the habitat range of Dolosigranulum through the analysis of 8184 samples from different body sites: interestingly, it was not detected in vaginal samples [62]. As hypothesized by Bosch et al., the impact of delivery mode on URT microbiota is probably more related to indirect mechanisms rather than a direct effect of the maternal vaginal environment [59].
Moreover, the dissimilarities in microbial communities related to delivery mode appear to be transient until six weeks of age, thus the body site itself could have a major impact on the microbiota in the postnatal period [63].

3.3. Smoking

Smoking, whether active or passive, is a major risk factor for respiratory disease, as it induces ciliostasis, goblet cell hyperplasia, and mucus hypersecretion, which could cause accumulation of mucus and bacteria in the URT and subsequently in the middle ear [64]. Moreover, it has been shown that passive smoking favors nasopharyngeal colonization by otopathogens [65].
In our research, we did not find any study concerning nasopharyngeal microbiota and smoking influence on pediatric age. Moreover, most of the studies on this topic have focused on the oropharyngeal/gengival environment and have investigated the potential relation to periodontal disease. Some preliminary data have been provided by Charlson et al., who compared nasopharyngeal microbial communities between 29 smoking and 33 nonsmoking adults, showing a higher abundance of Haemophilus spp. and other gram-positive anaerobic lineages in smokers [66].
It is well-known that passive smoking has a major negative impact on the nasal mucosa, inducing loss of cilia, hyperplasia of goblet cells, vascular congestion [67], and favoring biofilm formation [68]. On this basis, it is reasonable to speculate that smoking could have an impact also on microbial communities, as a consequence of the damaged nasal mucosa.
However, further studies with more consistent data are surely needed to deepen our knowledge on this topic and to better define the negative impact of smoking on respiratory health from the microbiota perspective.

3.4. Daycare Attendance

Daycare attendance constitutes a strong risk factor for AOM, most likely due to the increased exposure to the main colonizing otopathogens and to respiratory viral agents [69].
In particular, an early introduction to community life is strongly associated with an incremental risk of AOM: in a prospective study conducted in The Netherlands, children who started daycare at 6–12 months of age suffered from a higher number of AOM episodes, received more antibiotic prescriptions and underwent more medical visits [70], while another observational study on 1056 children showed an increased risk for AOM by 22% every month of age less the baby started daycare in the first year of life [71]. On the other hand, as expected, a 1.5% risk reduction in having 3 or more episodes of AOM for each month not attending daycare has been described [30].
We did not find any study with a specific design on this topic in relation to OM and URT microbiota. Some data are provided by studies in which authors have investigated nasopharyngeal microbiota in children taking into account several risk and epidemiological factors, without a precise focus on daycare attendance.
For instance, in a landmark study by Bosch et al., the authors evaluated the most important environmental drivers in relation to URT microbiota development, describing how children undergoing a higher number of infectious recurrences had an aberrant microbiota development, defined by a prolonged reduction of Corynebacterium and Dolosigranulum and early enrichment of Moraxella. Among others, daycare attendance was associated with this aberrant trajectory, which related to worse clinical outcomes [42].
Xu et al. investigated nasopharyngeal (NP) microbiota by comparing stringently-defined otitis prone children (sOP) versus AOM-free children at 6 and 12 months of age, showing a different microbial profile and a reduced alpha diversity in the sOP group at 6 months. In particular, genera such as Bacillus, Prevotella, Gemella, Veillonella, and Actinomyces were less abundant in sOP samples. The two most important factors associated with these differences were S. pneumoniae colonization and daycare attendance, indicating that the latter might have a significant impact on the whole community composition and contribute to dysbiosis at this age [72].
Close contact with other children and continuous exposure to infectious agents, both viral and bacterial, likely impairs the normal composition of microbial communities, especially in the URT. Mounting evidence shows indeed that several viral infections that are common in childhood can impair the stability of the respiratory microbiota, as described in relation to rhinovirus [73,74], influenza [75], and respiratory syncytial virus [73].
In general, viral upper respiratory tract infections are related to a higher colonization rate by otopathogens, especially in symptomatic cases, as shown by studies conducted both with standard PCR than with NGS techniques [76,77]. On the other hand, an enrichment in otopathogens has been associated with a higher recurrence of upper respiratory tract infections [76].
Daycare attendance, through a repeating exposure to viral agents, could be a starting point for a vicious cycle of recurrent viral disease and subsequent AOM episodes. However, our knowledge of viral-bacterial interactions in the URT is not fully elucidated, mainly because of the intrinsic limit of the most commonly used high throughput techniques applied in microbiome studies, which prevent a comprehensive evaluation of the whole virome and bacteriome at the same time.

3.5. Season

The incidence of AOM is higher in autumn and winter and is lower during spring and summer. Cold seasons are indeed characterized by a higher incidence of upper respiratory tract infections, which often precede an AOM episode [78]. In particular, in a recent Korean study, December was identified as the most common month for AOM occurrence, while June through September had low AOM occurrence and July had the least number of AOM cases each year [56].
The composition of microbial communities is influenced by season at sample collection [79]. In one of the first studies evaluating URT microbiota in children, Bogaert et al. analyzed samples from 96 healthy children and compared microbiota composition in those collected in winter/fall versus those collected in spring, reporting for the first time differences in NP microbiota according to seasonality with an NGS technique; in particular, samples obtained in fall/winter had a higher abundance of Proteobacteria, Fusobacteria and Cyanobacteria, while samples collected in spring were significantly enriched in Bacteroidetes [80]. Moreover, in a previously cited investigation evaluating the role of HMOs in human milk on the URT microbiome through shotgun metagenomics, season at sampling was the most relevant environmental factor shaping the microbial communities [48].
Winter season has been associated with a reduced relative abundance of the potential protective genera Corynebacterium and with a higher abundance of S. pneumoniae in the same period of the year [44]. Longitudinal data have been provided by Mika et al., who analyzed 872 nasal swabs from 47 children during the first year of life: at the family level, Corynebacteriaceae, which include potential protective bacteria, were more abundant in summer months; on the other hand, Pasteurellaceae, which among others comprehend the Haemophilus spp., were more abundant during winter, showing an outgrowth of potential otopathogens during this season [81]. Not only do microbial communities seem to be influenced by season fluctuations, but also season at birth has an impact on nasopharyngeal microbiota; as shown by Schoos et al., early bacterial colonization at 1 month of age was influenced by the season of birth, as bacterial richness was higher in infants born in the summer [82].
Seasonality is associated with respiratory diseases, which usually occur more often in winter than during summer [83]. Taken together, data show that the microbial communities in the URT are influenced by seasonality, providing a potential additional explanation for the correlation between a certain period of the year and respiratory recurrencies. Several hypotheses can be considered to explain this correlation: first of all, as previously discussed, viral agents can impair the homeostasis in microbial communities, and the seasonality of circulation of respiratory viruses is widely recognized [84]; moreover, seasonal variations in immune system functions have been described, contributing to the incidence of respiratory infection and, in our opinion, potentially influencing the composition of microbial communities [83]; lastly, the composition of URT microbiota has been also correlated to levels of circulating vitamin D, whose production is enhanced during summer [85].

3.6. Presence of Siblings

The presence of siblings nearly doubles the risk of presenting an episode of AOM and enhances the risk of RAOM in the first two years of life [69,86]. However, available studies also agree that it is still hard to correctly value the weight of the genetic influence between siblings in comparison to the sharing of the same familiar environment [87].
The higher incidence of respiratory infections in children with older siblings is related not only to a higher risk of transmission of viral agents, as the possibility of bacterial pathogens transmission, including S. pneumoniae, from one sibling to the other one has been demonstrated [88]. It is therefore plausible that the presence of siblings could impact the whole community composition in the URT.
In a cross-sectional study of 105 healthy infants aged <1 year, infants with siblings were colonized by profiles enriched in Moraxella and lacking in Corynebacterium/Dolosigranulum, while only children had an opposite pattern [89]. A lower abundance of Corynebacterium in the URT of children with siblings was later confirmed in a longitudinal study evaluating determinants of nasal microbiota development in the first 18 months of life [90].
Concerning otopathogens, a study conducted by Bosch et al. showed an association between the presence of siblings and increased abundance of Pasturellaceae, which includes Haemophilus spp. [42].

3.7. Air Pollution

The association between air pollution and OM has been demonstrated in studies conducted both in vivo and in vitro. Pollution facilitates the development of OM by promoting apoptosis, expression of inflammatory cytokines (TNF-α and COX-2), and expression of mucin genes in vitro [91], while the injection of pollution particles into the ME of animals increases the thickness of the ME mucosa, promotes infiltration of inflammatory cells and inhibits the expression of epithelial sodium channels, whose purpose is to maintain the ME free of fluids [92]. In particular, an increase in the concentration of PM 2.5 appears to better correlate with the development of OM compared with PM 10, especially in children under 2 years of age [93]. On the other hand, a systematic review conducted by Bowatte et al. included 24 observational studies and concluded that the evidence of a causal relationship between pollutants and otitis media is still limited [94].
Evidence on the impact of pollution on the URT microbiota in the pediatric age is lacking. A recent longitudinal study evaluated the potential impact of greenness and air pollution on the nasal microbiota of 47 healthy infants in the first year of life, showing that increased NO2 levels were related to a lower abundance of Corynebacterium and that low-to-moderate exposure levels could impact the URT microbiota composition in infants; on the other hand, no correlation was identified between PM 2.5 and abundance of Corynebacterium [95]. Potential mechanisms through which pollution could induce dysbiosis include modifications of the airway physiological environment and epithelial damage [96].
An overview of the studies discussed in this review is available in Table 1.

3.8. Impact of Pneumococcal Vaccination

The introduction of the pneumococcal conjugate vaccination (PCV) has determined an important reduction of OM episodes caused by the serotypes included in the vaccine [97]. A relevant epidemiological study conducted in Sweden on a large cohort has shown that the incidence of AOM has decreased 41.5% and 20.9% in children younger or older than 4 years old, respectively [98]. Similarly, several other epidemiological studies conducted in different countries have reported a reduction in AOM episodes, antibiotic consumption and transtympanic tube placement after the introduction of PCV [99,100,101,102,103]. A Cochrane review by Fortainier et al. evaluated 9 randomized controlled trials including 48.426 children and analyzed the impact on AOM frequency of PCV7, PCV9 and PCV11 conjugated with protein D from H. influenzae (PD-PCV11): PCV7 was associated to a reduction of 7% of relative risk if administered in the first year of life, while a higher reduction was identified in relation to AOM specifically caused by S. pneumoniae (20% and 52% for PCV7 e PCV11). Moreover, administration of PCV7 was related to a 9–10% reduction in risk of RAOM in children under 1 year of age [104].
The introduction of pneumococcal vaccination programs has induced modifications in OM microbiology, as H. influenzae has become the most common otopathogen and serotypes not included in PCVs have been more frequently identified as causative agents of AOM [6,105]. Considering these findings, it is reasonable to speculate that pneumococcal vaccination could impact the composition of the whole bacterial communities in the respiratory system. Unfortunately, evidence available so far on this topic is mostly focused on otopathogens rather than on an analysis of microbiota with high-throughput methods. Moreover, when available, these studies show conflicting results.
Preliminary data have been provided by Hilty et al. in one of the first investigations evaluating the whole URT microbiota in AOM: a previous exposure to PCV7 in children with AOM was associated with a reduced abundance of commensal families such as Streptococcaceae and Corynebacteriaceae [106]. Biesbroek and colleagues later investigated the impact of PCV7 on URT microbiota by collecting NP swabs from healthy children who received PCV7 and from unvaccinated ones, reporting that vaccination caused a shift in composition and structure of the bacterial community, with an increase of Veillonella, Prevotella, Fusobacterium, Leptotrichia, Actinomyces, Rothia, and nonpneumococcal streptococci [107]. PCV7 and PCV13 and their impact on URT microbiota were further evaluated in a longitudinal study by Mika et al., in which children vaccinated with PCV13 showed a more diverse and stable microbiota and a lower pneumococcal carriage rate compared to those who received PCV7 [108]. On the other hand, it should be noted that other available evidence suggests that PCV might not have a significant influence on the URT microbiota [109,110,111].
In conclusion, the main findings show that PCVs might have a direct effect on the pneumococcal carriage, with a subsequent possible secondary indirect effect on the whole NP microbiota. However, the difference in pneumococcal carriage rates in relation to geographic region and socio-economic status complicates the interpretation and comparison of the results from different studies, which appear still conflicting so far [112].

4. Discussion

In the URT, Dolosigranulum spp. and Corynebacterium spp. have been strongly associated with health status and have been defined as potential keystone species in this site [20,21,22,23].
Concerning Dolosigranulum pigrum, it has been hypothesized that the local production of lactic acid could be related to the lower identification rates of S. pneumoniae [113]. However, one of the first detailed studies on this microorganism, conducted by Brugger et al., evidenced that other factors contribute to its anti-pneumococcal activity: possible additional mechanisms proposed by the authors include indeed the competition for nutrients and the production of inhibitory substances, as the genomic analysis of D. pigrum strains revealed diverse biosynthetic gene clusters potentially encoding bacteriocins [54]. Moreover, studies conducted on animal models reported a potential immune-modulatory effect through the activation of Toll-like receptors (TLR-2 and TLR-3) and an induction of enhanced inflammatory response in the first stages of infection through an increased number of neutrophils, macrophages, and higher levels of IL-1β, IFN-γ, and IL-6 [114,115].
Regarding Corynebacterium, it has been reported that C. pseudodiphtericum is able to competitively exclude M. catharralis and improve resistance to RSV and pneumococcal infection in a murine model [116,117]. An interference assay conducted by Lappan et al. in order to assess the inhibitory activity of C. pseudodiphtericum and D. pigrum against the otopathogens confirmed the ability of C. pseudodiphtericum to inhibit M. catarrhalis growth; the authors supposed that this effect could be related not to the production of antimicrobial substances, yet to other mechanisms such as competition for nutrients [118].
In our review, the majority of the evidence analyzed showed that environmental risk factors for AOM impair the URT microbiota primarily causing a reduction in the relative abundance of these two potential beneficial microorganisms. Studies available to date are mostly associative and lack a functional analysis of the microorganisms identified as potentially protective; however, in recent years growing evidence is deepening our knowledge of the microbiological aspects, further validating the role of D. pigrum and C. pseudodiphtericum as key bacteria of the URT.
Taken together, available studies disclose a relevant impact of environmental risk factors on the delicate balance of microbial communities in this region. We can hypothesize that a decreased abundance of potentially protective bacteria, which can be induced by external agents, can favor a higher colonization rate by respiratory pathogens, with a subsequent higher incidence of respiratory disease. Infective episodes, both viral and bacterial, and antibiotic consumption can in turn further sustain this imbalance, predisposing to a vicious cycle of recurrences. Moreover, evidence analyzed in this review shows how certain developmental trajectories and distinct microbiota profiles established since the first phases of life can predispose to respiratory disease at later ages. Environmental risk factors thus likely predispose to AOM incidence also through URT microbiota impairment, starting from birth and the first months of life via delivery route and type of feeding, and at a later time via other agents such as daycare attendance.

5. Limitations

Most of the studies identified in our research are observational, while investigations concerning the causative mechanisms and the cause-effect relations between a certain risk factor and the alteration of microbial communities are lacking. Moreover, the results of different microbiome studies are often difficult to compare because of dissimilarities in specimen collection, analysis, and data reporting.
Most of these studies have been conducted with 16S rRNA PCR, a marker gene analysis that, combined with next-generation sequencing techniques, permits the simultaneous characterization of a whole community. Even if this approach allows a fast and cost-effective analysis, there are also some limitations that should be considered: there is limited functional information, as it is not possible to determine whether taxa detected are active or inactive; low biomass samples are susceptible to over-amplification bias; the taxonomic resolution is usually limited to family or genus level. Full-gene 16S rRNA gene sequencing and metagenome and metatrascriptome analysis may overcome some of these limitations but are less adopted as they are relatively expensive and complex to perform.

6. Conclusions

The introduction of novel high-throughput techniques has changed our approach to the investigation of infectious diseases and has provided novel insights into AOM pathogenesis, through the identification of potential protective genera in the URT. Evidence shows a potential impact of the most relevant environmental risk factors on the overall composition of microbial communities in the URT and on the relative abundance of potential keystone genera. Deepening our knowledge of AOM epidemiology and pathogenesis under the microbiome perspective could be of remarkable importance to improve our preventive strategies, in particular through the development of probiotic therapies. In our opinion, further investigations should be focused on the following aspects:
  • Deepening our knowledge on the impact of both risk and protective factors, such as vaccinations
  • Exploring the cause-effective correlation between environmental agents and subsequent microbial modifications
  • Focusing on Corynebacterium and Dolosigranulum role in the URT, in order to define their possible use as probiotics.

Author Contributions

F.F. conceived and wrote the manuscript; P.B. conducted the literature search and contributed to drafting the manuscript; P.M., S.T. and M.G. revised the paper for important intellectual contribution. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Paradise, J.L.; Rockette, H.E.; Colborn, D.K.; Bernard, B.S.; Smith, C.G.; Kurs-Lasky, M.; Janosky, J.E. Otitis Media in 2253 Pittsburgh-Area Infants: Prevalence and Risk Factors during the First Two Years of Life. Pediatrics 1997, 99, 318–333. [Google Scholar] [CrossRef] [PubMed]
  2. Marom, T.; Marchisio, P.G.; Tamir, S.O.; Torretta, S.; Gavriel, H.; Esposito, S. Complementary and Alternative Medicine Treatment Options for Otitis Media. Medicine 2016, 95, e2695. [Google Scholar] [CrossRef] [PubMed]
  3. Lieberthal, A.S.; Carroll, A.E.; Chonmaitree, T.; Ganiats, T.G.; Hoberman, A.; Jackson, M.A.; Joffe, M.D.; Miller, D.T.; Rosenfeld, R.M.; Sevilla, X.D.; et al. The Diagnosis and Management of Acute Otitis Media. Pediatrics 2013, 131, e964–e999. [Google Scholar] [CrossRef] [PubMed]
  4. Marchisio, P.G.; Cantarutti, L.; Sturkenboom, M.; Girotto, S.; Picelli, G.; Donà, D.; Scamarcia, A.; Villa, M.; Giaquinto, C. Burden of acute otitis media in primary care pediatrics in Italy: A secondary data analysis from the Pedianet database. BMC Pediatr. 2012, 12, 185. [Google Scholar] [CrossRef] [PubMed]
  5. Marchisio, P.G.; Nazzari, E.; Torretta, S.; Esposito, S.; Principi, N. Medical prevention of recurrent acute otitis media: An updated overview. Expert Rev. Anti-Infect. Ther. 2014, 12, 611–620. [Google Scholar] [CrossRef] [PubMed]
  6. Ngo, C.C.; Massa, H.M.; Thornton, R.B.; Cripps, A.W. Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLoS ONE 2016, 11, e0150949. [Google Scholar] [CrossRef]
  7. Heikkinen, T.; Chonmaitree, T. Importance of Respiratory Viruses in Acute Otitis Media. Clin. Microbiol. Rev. 2003, 16, 230–241. [Google Scholar] [CrossRef]
  8. Chonmaitree, T. Acute Otitis Media Is Not a Pure Bacterial Disease. Clin. Infect. Dis. 2006, 43, 1423–1425. [Google Scholar] [CrossRef]
  9. Bakaletz, L.O. Immunopathogenesis of polymicrobial otitis media. J. Leukoc. Biol. 2009, 87, 213–222. [Google Scholar] [CrossRef]
  10. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the Human Intestinal Microbial Flora. Science 2005, 308, 1635–1638. [Google Scholar] [CrossRef]
  11. Bernstein, J.M.; Reddy, M.S.; Scannapieco, F.A.; Faden, H.S.; Ballow, M. The Microbial Ecology and Immunology of the Adenoid: Implications for Otitis Media. Ann. N. Y. Acad. Sci. 1997, 830, 19–31. [Google Scholar] [CrossRef] [PubMed]
  12. Nistico, L.; Kreft, R.; Gieseke, A.; Coticchia, J.M.; Burrows, A.; Khampang, P.; Liu, Y.; Kerschner, J.E.; Post, J.C.; Lonergan, S.; et al. Adenoid Reservoir for Pathogenic Biofilm Bacteria. J. Clin. Microbiol. 2011, 49, 1411–1420. [Google Scholar] [CrossRef] [PubMed]
  13. Hoa, M.; Tomovic, S.; Nistico, L.; Hall-Stoodley, L.; Stoodley, P.; Sachdeva, L.; Berk, R.; Coticchia, J.M. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int. J. Pediatr. Otorhinolaryngol. 2009, 73, 1242–1248. [Google Scholar] [CrossRef] [PubMed]
  14. Bogaert, D.; de Groot, R.; Hermans, P.W.M. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect. Dis. 2004, 4, 144–154. [Google Scholar] [CrossRef]
  15. Piters, W.D.S.; Sanders, E.A.M.; Bogaert, D. The role of the local microbial ecosystem in respiratory health and disease. Philos. Trans. R. Soc. B Biol. Sci. 2015, 370, 20140294. [Google Scholar] [CrossRef]
  16. Peterson, J.; Garges, S.; Giovanni, M.; McInnes, P.; Wang, L.; Schloss, J.A.; Bonazzi, V.; McEwen, J.E.; Wetterstrand, K.A.; Deal, C.; et al. The NIH Human Microbiome Project. Genome Res. 2009, 19, 2317–2323. [Google Scholar] [CrossRef]
  17. Buffie, C.G.; Pamer, E.G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 2013, 13, 790–801. [Google Scholar] [CrossRef]
  18. Honda, K.; Littman, D.R. The Microbiome in Infectious Disease and Inflammation. Annu. Rev. Immunol. 2012, 30, 759–795. [Google Scholar] [CrossRef]
  19. Man, W.H.; De Steenhuijsen Piters, W.A.A.; Bogaert, D. The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nat. Rev. Microbiol. 2017, 15, 259–270. [Google Scholar] [CrossRef]
  20. Pettigrew, M.M.; Laufer, A.S.; Gent, J.F.; Kong, Y.; Fennie, K.P.; Metlay, J.P. Upper Respiratory Tract Microbial Communities, Acute Otitis Media Pathogens, and Antibiotic Use in Healthy and Sick Children. Appl. Environ. Microbiol. 2012, 78, 6262–6270. [Google Scholar] [CrossRef]
  21. Laufer, A.S.; Metlay, J.P.; Gent, J.F.; Fennie, K.; Kong, Y.; Pettigrew, M.M. Microbial Communities of the Upper Respiratory Tract and Otitis Media in Children. mBio 2011, 2, e00245-10. [Google Scholar] [CrossRef] [PubMed]
  22. Bomar, L.; Brugger, S.D.; Yost, B.H.; Davies, S.S.; Lemon, K.P. Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols. mBio 2016, 7, e01725-15. [Google Scholar] [CrossRef] [PubMed]
  23. Lappan, R.; Imbrogno, K.; Sikazwe, C.; Anderson, D.; Mok, D.; Coates, H.; Vijayasekaran, S.; Bumbak, P.; Blyth, C.C.; Jamieson, S.E.; et al. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera. BMC Microbiol. 2018, 18, 13. [Google Scholar] [CrossRef] [PubMed]
  24. Costello, E.K.; Lauber, C.L.; Hamady, M.; Fierer, N.; Gordon, J.I.; Knight, R. Bacterial Community Variation in Human Body Habitats Across Space and Time. Science 2009, 326, 1694–1697. [Google Scholar] [CrossRef] [PubMed]
  25. Thomas, S.; Izard, J.; Walsh, E.; Batich, K.; Chongsathidkiet, P.; Clarke, G.; Sela, D.A.; Muller, A.J.; Mullin, J.M.; Albert, K.; et al. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res. 2017, 77, 1783–1812. [Google Scholar] [CrossRef] [PubMed]
  26. Charbonneau, M.R.; Blanton, L.V.; DiGiulio, D.B.; Relman, D.A.; Lebrilla, C.B.; Mills, D.A.; Gordon, J.I. A microbial perspective of human developmental biology. Nature 2016, 535, 48–55. [Google Scholar] [CrossRef]
  27. Schilder, A.G.M.; Chonmaitree, T.; Cripps, A.W.; Rosenfeld, R.M.; Casselbrant, M.L.; Haggard, M.P.; Venekamp, R.P. Otitis media. Nat. Rev. Dis. Primers 2016, 2, 16063. [Google Scholar] [CrossRef]
  28. Park, M.; Han, J.; Jang, M.-J.; Suh, M.-W.; Lee, J.H.; Oh, S.H.; Park, M.K. Air pollution influences the incidence of otitis media in children: A national population-based study. PLoS ONE 2018, 13, e0199296. [Google Scholar] [CrossRef]
  29. Kong, K.; Coates, H.L.C. Natural history, definitions, risk factors and burden of otitis media. Med. J. Aust. 2009, 191, S39–S43. [Google Scholar] [CrossRef]
  30. Kørvel-Hanquist, A.; Koch, A.; Lous, J.; Olsen, S.F.; Homøe, P. Risk of childhood otitis media with focus on potentially modifiable factors: A Danish follow-up cohort study. Int. J. Pediatr. Otorhinolaryngol. 2017, 106, 1–9. [Google Scholar] [CrossRef]
  31. Marchisio, P.; Bortone, B.; Ciarcià, M.; Motisi, M.A.; Torretta, S.; Gattinara, G.C.; Picca, M.; Di Mauro, G.; Bonino, M.; Mansi, N.; et al. Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Prevention. Pediatr. Infect. Dis. J. 2019, 38, S22–S36. [Google Scholar] [CrossRef]
  32. Vergison, A.; Dagan, R.; Arguedas, A.; Bonhoeffer, J.; Cohen, R.; Dhooge, I.; Hoberman, A.; Liese, J.; Marchisio, P.G.; Palmu, A.A.; et al. Otitis media and its consequences: Beyond the earache. Lancet Infect. Dis. 2010, 10, 195–203. [Google Scholar] [CrossRef]
  33. Tarrant, M.; Kwok, M.-K.; Lam, T.-H.; Leung, G.M.; Schooling, C.M. Breast-feeding and Childhood Hospitalizations for Infections. Epidemiology 2010, 21, 847–854. [Google Scholar] [CrossRef] [PubMed]
  34. Duijts, L.; Jaddoe, V.W.V.; Hofman, A.; Moll, H.A. Prolonged and Exclusive Breastfeeding Reduces the Risk of Infectious Diseases in Infancy. Pediatrics 2010, 126, e18–e25. [Google Scholar] [CrossRef] [PubMed]
  35. Teele, D.W.; Klein, J.O.; Rosner, B. Greater Boston Otitis Media Study Group Epidemiology of Otitis Media During the First Seven Years of Life in Children in Greater Boston: A Prospective, Cohort Study. J. Infect. Dis. 1989, 160, 83–94. [Google Scholar] [CrossRef] [PubMed]
  36. Duncan, B.; Ey, J.; Holberg, C.J.; Wright, A.L.; Martinez, F.D.; Taussig, L.M. Exclusive Breast-Feeding for at Least 4 Months Protects Against Otitis Media. Pediatrics 1993, 91, 867–872. [Google Scholar] [CrossRef]
  37. Saarinen, U.M. Prolonged breast feeding as prophylaxis for recurrent otitis media. Acta Paediatr. 1982, 71, 567–571. [Google Scholar] [CrossRef]
  38. Bowatte, G.; Tham, R.; Allen, K.J.; Tan, D.J.; Lau, M.; Dai, X.; Lodge, C.J. Breastfeeding and childhood acute otitis media: A systematic review and meta-analysis. Acta Paediatr. 2015, 104, 85–95. [Google Scholar] [CrossRef]
  39. Labbok, M.H.; Clark, D.; Goldman, A.S. Breastfeeding: Maintaining an irreplaceable immunological resource. Nat. Rev. Immunol. 2004, 4, 565–572. [Google Scholar] [CrossRef]
  40. Biesbroek, G.; Bosch, A.A.T.M.; Wang, X.; Keijser, B.J.F.; Veenhoven, R.H.; Sanders, E.A.M.; Bogaert, D. The Impact of Breastfeeding on Nasopharyngeal Microbial Communities in Infants. Am. J. Respir. Crit. Care Med. 2014, 190, 298–308. [Google Scholar] [CrossRef]
  41. Biesbroek, G.; Tsivtsivadze, E.; Sanders, E.A.M.; Montijn, R.; Veenhoven, R.H.; Keijser, B.J.F.; Bogaert, D. Early Respiratory Microbiota Composition Determines Bacterial Succession Patterns and Respiratory Health in Children. Am. J. Respir. Crit. Care Med. 2014, 190, 1283–1292. [Google Scholar] [CrossRef] [PubMed]
  42. Bosch, A.A.T.M.; De Steenhuijsen Piters, W.A.A.; Van Houten, M.A.; Chu, M.L.J.N.; Biesbroek, G.; Kool, J.; Pernet, P.; De Groot, P.K.C.M.; Eijkemans, M.J.C.; Keijser, B.J.F.; et al. Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. Am. J. Respir. Crit. Care Med. 2017, 196, 1582–1590. [Google Scholar] [CrossRef]
  43. Camelo-Castillo, A.; Henares, D.; Brotons, P.; Galiana, A.; Rodríguez, J.C.; Mira, A.; Muñoz-Almagro, C. on behalf of the Catalan Study Group of Host- Pathogen Interaction in Patients With IPD. Nasopharyngeal Microbiota in Children with Invasive Pneumococcal Disease: Identification of Bacteria with Potential Disease-Promoting and Protective Effects. Front. Microbiol. 2019, 10, 11. [Google Scholar] [CrossRef] [PubMed]
  44. Kelly, M.S.; Plunkett, C.; Yu, Y.; Aquino, J.N.; Patel, S.M.; Hurst, J.H.; Young, R.R.; Smieja, M.; Steenhoff, A.P.; Arscott-Mills, T.; et al. Non-diphtheriae Corynebacterium species are associated with decreased risk of pneumococcal colonization during infancy. ISME J. 2021, 16, 655–665. [Google Scholar] [CrossRef] [PubMed]
  45. Henares, D.; Brotons, P.; de Sevilla, M.F.; Fernandez-Lopez, A.; Hernandez-Bou, S.; Perez-Argüello, A.; Mira, A.; Muñoz-Almagro, C.; Cabrera-Rubio, R. Differential nasopharyngeal microbiota composition in children according to respiratory health status. Microb. Genom. 2021, 7, 000661. [Google Scholar] [CrossRef]
  46. Newburg, D.S. Human Milk Glycoconjugates That Inhibit Pathogens. Curr. Med. Chem. 1999, 6, 117–127. [Google Scholar] [CrossRef]
  47. Doherty, A.M.; Lodge, C.J.; Dharmage, S.C.; Dai, X.; Bode, L.; Lowe, A.J. Human Milk Oligosaccharides and Associations with Immune-Mediated Disease and Infection in Childhood: A Systematic Review. Front. Pediatr. 2018, 6, 91. [Google Scholar] [CrossRef]
  48. Binia, A.; Siegwald, L.; Sultana, S.; Shevlyakova, M.; Lefebvre, G.; Foata, F.; Combremont, S.; Charpagne, A.; Vidal, K.; Sprenger, N.; et al. The Influence of FUT2 and FUT3 Polymorphisms and Nasopharyngeal Microbiome on Respiratory Infections in Breastfed Bangladeshi Infants from the Microbiota and Health Study. mSphere 2021, 6, e00686-21. [Google Scholar] [CrossRef]
  49. Hunt, K.M.; Foster, J.A.; Forney, L.J.; Schütte, U.M.E.; Beck, D.L.; Abdo, Z.; Fox, L.K.; Williams, J.E.; McGuire, M.K.; McGuire, M.A. Characterization of the Diversity and Temporal Stability of Bacterial Communities in Human Milk. PLoS ONE 2011, 6, e21313. [Google Scholar] [CrossRef]
  50. Zimmermann, P.; Curtis, N. Breast milk microbiota: A review of the factors that influence composition. J. Infect. 2020, 81, 17–47. [Google Scholar] [CrossRef]
  51. Fernández, L.; Pannaraj, P.S.; Rautava, S.; Rodríguez, J.M. The Microbiota of the Human Mammary Ecosystem. Front. Cell. Infect. Microbiol. 2020, 10, 586667. [Google Scholar] [CrossRef]
  52. Drago, L.; Toscano, M.; De Grandi, R.; Grossi, E.; Padovani, E.M.; Peroni, D.G. Microbiota network and mathematic microbe mutualism in colostrum and mature milk collected in two different geographic areas: Italy versus Burundi. ISME J. 2016, 11, 875–884. [Google Scholar] [CrossRef] [PubMed]
  53. Grice, E.A.; Segre, J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, 9, 244–253. [Google Scholar] [CrossRef] [PubMed]
  54. Brugger, S.D.; Eslami, S.M.; Pettigrew, M.M.; Escapa, I.F.; Henke, M.T.; Kong, Y.; Lemon, K.P. Dolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota. mSphere 2020, 5, e00852-20. [Google Scholar] [CrossRef] [PubMed]
  55. Guibas, G.V.; Moschonis, G.; Xepapadaki, P.; Roumpedaki, E.; Androutsos, O.; Manios, Y.; Papadopoulos, N.G. Conception via in vitro fertilization and delivery by Caesarean section are associated with paediatric asthma incidence. Clin. Exp. Allergy 2013, 43, 1058–1066. [Google Scholar] [CrossRef]
  56. Kristensen, K.; Fisker, N.; Haerskjold, A.; Ravn, H.; Simões, E.A.F.; Stensballe, L. Caesarean Section and Hospitalization for Respiratory Syncytial Virus Infection. Pediatr. Infect. Dis. J. 2015, 34, 145–148. [Google Scholar] [CrossRef]
  57. Hartley, M.; Woolcott, C.G.; Langley, J.M.; Brown, M.M.; Ashley-Martin, J.; Kuhle, S. Birth by Caesarean section and otitis media in childhood: A retrospective cohort study. Sci. Rep. 2020, 10, 5219. [Google Scholar] [CrossRef]
  58. Jakobsson, H.E.; Abrahamsson, T.R.; Jenmalm, M.C.; Harris, K.; Quince, C.; Jernberg, C.; Björkstén, B.; Engstrand, L.; Andersson, A.F. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 2013, 63, 559–566. [Google Scholar] [CrossRef]
  59. Bosch, A.A.; Levin, E.; van Houten, M.A.; Hasrat, R.; Kalkman, G.; Biesbroek, G.; Piters, W.A.D.S.; de Groot, P.-K.C.; Pernet, P.; Keijser, B.J.; et al. Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery. eBioMedicine 2016, 9, 336–345. [Google Scholar] [CrossRef]
  60. Dominguez-Bello, M.G.; Costello, E.K.; Contreras, M.; Magris, M.; Hidalgo, G.; Fierer, N.; Knight, R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 2010, 107, 11971–11975. [Google Scholar] [CrossRef]
  61. Smith, S.B.; Ravel, J. The vaginal microbiota, host defence and reproductive physiology. J. Physiol. 2016, 595, 451–463. [Google Scholar] [CrossRef] [PubMed]
  62. De Boeck, I.; Wittouck, S.; Martens, K.; Spacova, I.; Cauwenberghs, E.; Allonsius, C.N.; Jörissen, J.; Wuyts, S.; Van Beeck, W.; Dillen, J.; et al. The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms. iScience 2021, 24, 102978. [Google Scholar] [CrossRef] [PubMed]
  63. Chu, D.M.; Ma, J.; Prince, A.L.; Antony, K.M.; Seferovic, M.D.; Aagaard, D.M.; Kjersti, M. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 2017, 23, 314–326. [Google Scholar] [CrossRef] [PubMed]
  64. Etzel, R.A.; Pattishall, E.N.; Haley, N.J.; Fletcher, R.H.; Henderson, F.W. Passive Smoking and Middle Ear Effusion among Children in Day Care. Pediatrics 1992, 90, 228–232. [Google Scholar] [CrossRef]
  65. Greenberg, D.; Givon-Lavi, N.; Broides, A.; Blancovich, I.; Peled, N.; Dagan, R. The Contribution of Smoking and Exposure to Tobacco Smoke to Streptococcus pneumoniae and Haemophilus influenzae Carriage in Children and Their Mothers. Clin. Infect. Dis. 2006, 42, 897–903. [Google Scholar] [CrossRef]
  66. Charlson, E.S.; Chen, J.; Custers-Allen, R.; Bittinger, K.; Li, H.; Sinha, R.; Hwang, J.; Bushman, F.D.; Collman, R.G. Disordered Microbial Communities in the Upper Respiratory Tract of Cigarette Smokers. PLoS ONE 2010, 5, e15216. [Google Scholar] [CrossRef]
  67. Elwany, S.; Ibrahim, A.A.; Mandour, Z.; Talaat, I. Effect of passive smoking on the ultrastructure of the nasal mucosa in children. Laryngoscope 2012, 122, 965–969. [Google Scholar] [CrossRef]
  68. Elwany, S.; Gamea, M.A.; Talaat, I. Passive smoking induces nasal biofilms in children. Int. J. Pediatr. Otorhinolaryngol. 2021, 146, 110755. [Google Scholar] [CrossRef]
  69. Ladomenou, F.; Kafatos, A.; Tselentis, Y.; Galanakis, E. Predisposing factors for acute otitis media in infancy. J. Infect. 2010, 61, 49–53. [Google Scholar] [CrossRef]
  70. La De Hoog, M.; Venekamp, R.P.; Van Der Ent, C.K.; Schilder, A.; Sanders, E.A.; Damoiseaux, R.A.; Bogaert, D.; Uiterwaal, C.S.; Smit, H.A.; Bruijning-Verhagen, P. Impact of early daycare on healthcare resource use related to upper respiratory tract infections during childhood: Prospective WHISTLER cohort study. BMC Med. 2014, 12, 107. [Google Scholar] [CrossRef]
  71. Ginkel, A.C.P.-V.; Bruijning-Verhagen, P.; Uiterwaal, C.S.P.M.; van der Ent, C.K.; Smit, H.A.; de Hoog, M.L.A. Acute Otitis Media During Infancy. Pediatr. Infect. Dis. J. 2017, 36, 245–249. [Google Scholar] [CrossRef] [PubMed]
  72. Xu, L.; Earl, J.; Bajorski, P.; Gonzalez, E.; Pichichero, M.E. Nasopharyngeal microbiome analyses in otitis-prone and otitis-free children. Int. J. Pediatr. Otorhinolaryngol. 2021, 143, 110629. [Google Scholar] [CrossRef] [PubMed]
  73. Rosas-Salazar, C.; Shilts, M.H.; Tovchigrechko, A.; Schobel, S.; Chappell, J.D.; Larkin, E.K.; Shankar, J.; Yooseph, S.; Nelson, K.E.; Halpin, R.A.; et al. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection with Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J. Infect. Dis. 2016, 214, 1924–1928. [Google Scholar] [CrossRef] [PubMed]
  74. Toivonen, L.; Camargo, C.A.; Gern, J.E.; Bochkov, Y.A.; Mansbach, J.M.; Piedra, P.A.; Hasegawa, K. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J. Allergy Clin. Immunol. 2019, 143, 1925–1928.e7. [Google Scholar] [CrossRef]
  75. Wen, Z.; Xie, G.; Zhou, Q.; Qiu, C.; Li, J.; Hu, Q.; Dai, W.; Li, D.; Zheng, Y.; Wen, F. Distinct Nasopharyngeal and Oropharyngeal Microbiota of Children with Influenza A Virus Compared with Healthy Children. BioMed Res. Int. 2018, 2018, 6362716. [Google Scholar] [CrossRef]
  76. Chonmaitree, T.; Jennings, K.; Golovko, G.; Khanipov, K.; Pimenova, M.; Patel, J.A.; McCormick, D.P.; Loeffelholz, M.J.; Fofanov, Y. Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media. PLoS ONE 2017, 12, e0180630. [Google Scholar] [CrossRef]
  77. DeMuri, G.P.; Gern, J.E.; Eickhoff, J.C.; Lynch, S.V.; Wald, E.R. Dynamics of Bacterial Colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during Symptomatic and Asymptomatic Viral Upper Respiratory Tract Infection. Clin. Infect. Dis. 2017, 66, 1045–1053. [Google Scholar] [CrossRef]
  78. Mandel, E.M.; Doyle, W.J.; Winther, B.; Alper, C.M. The incidence, prevalence and burden of OM in unselected children aged 1–8 years followed by weekly otoscopy through the “common cold” season. Int. J. Pediatr. Otorhinolaryngol. 2008, 72, 491–499. [Google Scholar] [CrossRef]
  79. Santee, C.A.; Nagalingam, N.A.; Faruqi, A.A.; DeMuri, G.P.; Gern, J.E.; Wald, E.R.; Lynch, S.V. Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. Microbiome 2016, 4, 34. [Google Scholar] [CrossRef]
  80. Bogaert, D.; Keijser, B.; Huse, S.; Rossen, J.; Veenhoven, R.; Van Gils, E.; Bruin, J.; Montijn, R.; Bonten, M.; Sanders, E. Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis. PLoS ONE 2011, 6, e17035. [Google Scholar] [CrossRef]
  81. Mika, M.; Mack, I.; Korten, I.; Qi, W.; Aebi, S.; Frey, U.; Latzin, P.; Hilty, M. Dynamics of the nasal microbiota in infancy: A prospective cohort study. J. Allergy Clin. Immunol. 2015, 135, 905–912.e11. [Google Scholar] [CrossRef] [PubMed]
  82. Schoos, A.-M.M.; Kragh, M.; Ahrens, P.; Kuhn, K.G.; Rasmussen, M.A.; Chawes, B.L.; Jensen, J.S.; Brix, S.; Bisgaard, H.; Stokholm, J. Season of Birth Impacts the Neonatal Nasopharyngeal Microbiota. Children 2020, 7, 45. [Google Scholar] [CrossRef] [PubMed]
  83. Paynter, S.; Ware, R.; Sly, P.; Williams, G.; Weinstein, P. Seasonal immune modulation in humans: Observed patterns and potential environmental drivers. J. Infect. 2015, 70, 1–10. [Google Scholar] [CrossRef]
  84. Moriyama, M.; Hugentobler, W.J.; Iwasaki, A. Seasonality of Respiratory Viral Infections. Annu. Rev. Virol. 2020, 7, 83–101. [Google Scholar] [CrossRef]
  85. Toivonen, L.; Hasegawa, K.; Ajami, N.J.; Celedón, J.C.; Mansbach, J.M.; Petrosino, J.F.; Camargo, C.A., Jr. Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity. Pediatr. Allergy Immunol. 2018, 29, 877–880. [Google Scholar] [CrossRef] [PubMed]
  86. Labout, J.A.M.; Duijts, L.; Lebon, A.; De Groot, R.; Hofman, A.; Jaddoe, V.V.W.; Verbrugh, H.A.; Hermans, P.W.M.; Moll, H.A. Risk factors for otitis media in children with special emphasis on the role of colonization with bacterial airway pathogens: The Generation R study. Eur. J. Epidemiol. 2010, 26, 61–66. [Google Scholar] [CrossRef]
  87. Neto, J.F.L.; Hemb, L.; e Silva, D.B. Systematic literature review of modifiable risk factors for recurrent acute otitis media in childhood. J. Pediatr. 2006, 82, 87–96. [Google Scholar] [CrossRef]
  88. Shimada, J.; Yamanaka, N.; Hotomi, M.; Suzumoto, M.; Sakai, A.; Ubukata, K.; Mitsuda, T.; Yokota, S.; Faden, H. Household Transmission of Streptococcus pneumoniae among Siblings with Acute Otitis Media. J. Clin. Microbiol. 2002, 40, 1851–1853. [Google Scholar] [CrossRef]
  89. Hasegawa, K.; Linnemann, R.W.; Mansbach, J.M.; Ajami, N.J.; Espinola, J.A.; Fiechtner, L.G.; Petrosino, J.F.; Camargo, C.A, Jr. Household siblings and nasal and fecal microbiota in infants. Pediatr. Int. 2016, 59, 473–481. [Google Scholar] [CrossRef]
  90. Ta, L.D.H.; Yap, G.C.; Tay, C.J.X.; Lim, A.S.M.; Huang, C.-H.; Chu, C.W.; De Sessions, P.F.; Shek, L.P.; Goh, A.; Van Bever, H.P.; et al. Establishment of the nasal microbiota in the first 18 months of life: Correlation with early-onset rhinitis and wheezing. J. Allergy Clin. Immunol. 2018, 142, 86–95. [Google Scholar] [CrossRef]
  91. Song, J.-J.; Lee, J.D.; Lee, B.D.; Chae, S.W.; Park, M.K. Effect of diesel exhaust particles on human middle ear epithelial cells. Int. J. Pediatr. Otorhinolaryngol. 2012, 76, 334–338. [Google Scholar] [CrossRef] [PubMed]
  92. Park, M.K.; Chae, S.W.; Kim, H.-B.; Cho, J.G.; Song, J.-J. Middle ear inflammation of rat induced by urban particles. Int. J. Pediatr. Otorhinolaryngol. 2014, 78, 2193–2197. [Google Scholar] [CrossRef] [PubMed]
  93. Lee, S.-Y.; Jang, M.-J.; Oh, S.H.; Lee, J.H.; Suh, M.-W.; Park, M.K. Associations between Particulate Matter and Otitis Media in Children: A Meta-Analysis. Int. J. Environ. Res. Public Health 2020, 17, 4604. [Google Scholar] [CrossRef] [PubMed]
  94. Bowatte, G.; Tham, R.; Perret, J.L.; Bloom, M.S.; Dong, G.; Waidyatillake, N.; Bui, D.; Morgan, G.G.; Jalaludin, B.; Lodge, C.J.; et al. Air Pollution and Otitis Media in Children: A Systematic Review of Literature. Int. J. Environ. Res. Public Health 2018, 15, 257. [Google Scholar] [CrossRef]
  95. Gisler, A.; Korten, I.; de Hoogh, K.; Vienneau, D.; Frey, U.; Decrue, F.; Gorlanova, O.; Soti, A.; Hilty, M.; Latzin, P.; et al. Associations of air pollution and greenness with the nasal microbiota of healthy infants: A longitudinal study. Environ. Res. 2021, 202, 111633. [Google Scholar] [CrossRef]
  96. Xue, Y.; Chu, J.; Li, Y.; Kong, X. The influence of air pollution on respiratory microbiome: A link to respiratory disease. Toxicol. Lett. 2020, 334, 14–20. [Google Scholar] [CrossRef]
  97. Pettigrew, M.M.; Alderson, M.R.; Bakaletz, L.O.; Barenkamp, S.J.; Hakansson, A.P.; Mason, K.M.; Nokso-Koivisto, J.; Patel, J.; Pelton, S.I.; Murphy, T.F. Panel 6: Vaccines. Otolaryngol. Neck Surg. 2017, 156 (Suppl. 4), S76–S87. [Google Scholar] [CrossRef]
  98. Johansson Kostenniemi, U.; Palm, J.; Silfverdal, S.-A. Reductions in otitis and other respiratory tract infections following childhood pneumococcal vaccination. Acta Paediatr. 2018, 107, 1601–1609. [Google Scholar] [CrossRef]
  99. Magnus, M.C.; Vestrheim, D.F.; Nystad, W.; Håberg, S.E.; Stigum, H.; London, S.J.; Bergsaker, M.A.R.; Caugant, D.A.; Aaberge, I.S.; Nafstad, P. Decline in Early Childhood Respiratory Tract Infections in the Norwegian Mother and Child Cohort Study After Introduction of Pneumococcal Conjugate Vaccination. Pediatr. Infect. Dis. J. 2012, 31, 951–955. [Google Scholar] [CrossRef]
  100. Stamboulidis, K.; Chatzaki, D.; Poulakou, G.; Ioannidou, S.; Lebessi, E.; Katsarolis, I.; Sypsa, V.; Tsakanikos, M.; Kafetzis, D.; Tsolia, M.N. The Impact of the Heptavalent Pneumococcal Conjugate Vaccine on the Epidemiology of Acute Otitis Media Complicated by Otorrhea. Pediatr. Infect. Dis. J. 2011, 30, 551–555. [Google Scholar] [CrossRef]
  101. Sugino, H.; Tsumura, S.; Kunimoto, M.; Noda, M.; Chikuie, D.; Noda, C.; Yamashita, M.; Watanabe, H.; Ishii, H.; Tashiro, T.; et al. Influence of Pneumococcal Conjugate Vaccine on Acute Otitis Media with Severe Middle Ear Inflammation: A Retrospective Multicenter Study. PLoS ONE 2015, 10, e0137546. [Google Scholar] [CrossRef] [PubMed]
  102. Suarez, V.; Michel, F.; Toscano, C.M.; Bierrenbach, A.L.; Gonzales, M.; Alencar, A.P.; Matus, C.R.; Andrus, J.K.; de Oliveira, L.H. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses. Vaccine 2016, 34, 4738–4743. [Google Scholar] [CrossRef] [PubMed]
  103. Ochoa-Gondar, O.; Figuerola-Massana, E.; Vila-Corcoles, A.; Aguirre, C.A.; de Diego, C.; Satue, E.; Gomez, F.; Raga, X.; EPIVAC Study Group. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007–2013: Incidence, serotype distribution and vaccine’s effectiveness. Int. J. Pediatr. Otorhinolaryngol. 2015, 79, 2104–2108. [Google Scholar] [CrossRef] [PubMed]
  104. Fortanier, A.C.; Venekamp, R.P.; Boonacker, C.W.; Hak, E.; Schilder, A.G.; Sanders, E.A.; Damoiseaux, R.A. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst. Rev. 2014, 4, CD001480. [Google Scholar] [CrossRef] [PubMed]
  105. Gladstone, R.A.; Jefferies, J.M.; Tocheva, A.S.; Beard, K.R.; Garley, D.; Chong, W.W.; Bentley, S.D.; Faust, S.; Clarke, S.C. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 2015, 33, 2015–2021. [Google Scholar] [CrossRef]
  106. Hilty, M.; Qi, W.; Brugger, S.D.; Frei, L.; Agyeman, P.K.A.; Frey, P.; Aebi, S.; Mühlemann, K. Nasopharyngeal Microbiota in Infants with Acute Otitis Media. J. Infect. Dis. 2012, 205, 1048–1055. [Google Scholar] [CrossRef]
  107. Biesbroek, G.; Wang, X.; Keijser, B.J.; Eijkemans, R.M.; Trzciński, K.; Rots, N.Y.; Veenhoven, R.H.; Sanders, E.A.; Bogaert, D. Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children. Emerg. Infect. Dis. 2014, 20, 201–210. [Google Scholar] [CrossRef]
  108. Mika, M.; Maurer, J.; Korten, I.; Allemann, A.; Aebi, S.; Brugger, S.D.; Qi, W.; Frey, U.; Latzin, P.; Hilty, M. Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: A longitudinal analysis of a case–control study. Microbiome 2017, 5, 85. [Google Scholar] [CrossRef]
  109. Feazel, L.M.; Santorico, S.A.; Robertson, C.E.; Bashraheil, M.; Scott, J.A.G.; Frank, D.N.; Hammitt, L.L. Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers. PLoS ONE 2015, 10, e0128064. [Google Scholar] [CrossRef]
  110. Kwambana-Adams, B.; Hanson, B.; Worwui, A.; Agbla, S.; Foster-Nyarko, E.; Ceesay, F.; Ebruke, C.; Egere, U.; Zhou, Y.; Ndukum, M.; et al. Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology. Sci. Rep. 2017, 7, 8127. [Google Scholar] [CrossRef]
  111. Andrade, D.C.; Borges, I.C.; Bouzas, M.L.; Oliveira, J.R.; Fukutani, K.F.; Queiroz, A.T.; de Oliveira, C.I.; Barral, A.; Van Weyenbergh, J.; Naschimento-Carvalho, C. 10-valent pneumococcal conjugate vaccine (PCV10) decreases metabolic activity but not nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Vaccine 2017, 35, 4105–4111. [Google Scholar] [CrossRef] [PubMed]
  112. Adegbola, R.A.; DeAntonio, R.; Hill, P.C.; Roca, A.; Usuf, E.; Hoet, B.; Greenwood, B.M. Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis. PLoS ONE 2014, 9, e103293. [Google Scholar] [CrossRef] [PubMed]
  113. De Steenhuijsen Piters, W.A.A.; Bogaert, D. Unraveling the Molecular Mechanisms Underlying the Nasopharyngeal Bacterial Community Structure. mBio 2016, 7, e00009-16. [Google Scholar] [CrossRef] [PubMed]
  114. Moyano, R.O.; Tonetti, F.R.; Tomokiyo, M.; Kanmani, P.; Vizoso-Pinto, M.G.; Kim, H.; Quilodrán-Vega, S.; Melnikov, V.; Alvarez, S.; Takahashi, H.; et al. The Ability of Respiratory Commensal Bacteria to Beneficially Modulate the Lung Innate Immune Response Is a Strain Dependent Characteristic. Microorganisms 2020, 8, 727. [Google Scholar] [CrossRef] [PubMed]
  115. Tonetti, F.R.; Tomokiyo, M.; Moyano, R.O.; Quilodrán-Vega, S.; Yamamuro, H.; Kanmani, P.; Melnikov, V.; Kurata, S.; Kitazawa, H.; Villena, J. The Respiratory Commensal Bacterium Dolosigranulum pigrum 040417 Improves the Innate Immune Response to Streptococcus pneumoniae. Microorganisms 2021, 9, 1324. [Google Scholar] [CrossRef] [PubMed]
  116. Rikitomi, N.; Akiyama, M.; Matsumoto, K. Role of Normal Microflora in the Throat in Inhibition of Adherence of Pathogenic Bacteria to Host Cells. Kansenshogaku Zasshi 1989, 63, 118–124. [Google Scholar] [CrossRef]
  117. Kanmani, P.; Clua, P.; Vizoso-Pinto, M.G.; Rodriguez, C.; Alvarez, S.; Melnikov, V.; Takahashi, H.; Kitazawa, H.; Villena, J. Respiratory Commensal Bacteria Corynebacterium pseudodiphtheriticum Improves Resistance of Infant Mice to Respiratory Syncytial Virus and Streptococcus pneumoniae Superinfection. Front. Microbiol. 2017, 8, 1613. [Google Scholar] [CrossRef]
  118. Lappan, R. Using ’Omics Technologies to Understand Pathogenesis and Seek Alternative Therapies for Otitis Media in Children. Ph.D. Thesis, The University of Western Australia, Crawley, Australia, 2019. [Google Scholar] [CrossRef]
Figure 1. Search strategy conducted for this review.
Figure 1. Search strategy conducted for this review.
Applmicrobiol 02 00046 g001
Table 1. Overview of investigations on microbiota and recurrent acute otitis media environmental risk factors discussed in this review.
Table 1. Overview of investigations on microbiota and recurrent acute otitis media environmental risk factors discussed in this review.
Title
(Year of Publication)
[Ref]
Study DesignN. of SubjectsAgeEnvironmental FactorMain Findings
The Impact of Breastfeeding on Nasopharyngeal Microbial Communities in Infants
(2014)
[40]
Comparison of NP microbiota between infants
that had received exclusive breastfeeding and children that had received exclusive formula feeding
Exclusive breastfeeding
(n = 101)
Formula feeding
(n = 101)
<6 m
(samples collected at 6 weeks and 6 months of age in all subjects)
BreastfeedingAt 6 weeks of age: higher abundance of Dolosigranulum and Corynebacterium and decreased abundance of Staphylococcus and Prevotella in breastfed infants
Predominance of Corynebacterium and Dolosigranulum was observed in 44.6% of the breastfed infants compared with 18.8% formula-fed infants; Dolosigranulum abundance was inversely associated with incidence of mild RTIs
Early Respiratory Microbiota Composition Determines Bacterial Succession Patterns and Respiratory Health in Children
(2014)
[41]
Longitudinal URT microbiota analysis
in healthy children in the first 2 years of life
60 healthy children<2 years
(samples collected at 1.5, 6, 12, and 24 months of age)
BreastfeedingStable developmental patterns were characterized by early presence and higher abundance of Moraxella and Corynebacterium/Dolosigranulum
Moraxella and Corynebacterium/Dolosigranulum dominated profiles
were associated with breastfeeding and with lower rates of RTIs
Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences A Prospective Cohort Study
(2017)
[42]
Longitudinal URT microbiota analysis
in healthy children during the first year of life
112 infants
(1121 samples)
<1 year
(samples collected 2 h after birth, at 24 h, at 7 and 14 days, at 1, 2, 3, 4, 6, 9, and 12 months of age)
Breastfeeding
Delivery route
Daycare attendance
A higher incidence of RTIs in the first year of life was associated with an altered microbiota development from the first month of life on, consisting in a prolonged reduction of Corynebacterium and Dolosigranulum, early enrichment of Moraxella, later enrichment of Neisseria and Prevotella spp.
Independent drivers of these aberrant alterations were delivery route, feeding practices, crowding, recent antibiotic use
Nasopharyngeal Microbiota in Children With Invasive Pneumococcal Disease: Identification of Bacteria With Potential Disease-Promoting and Protective Effects (2019)
[43]
Comparison of URT microbiota in children with IPD and healthy controls 56 children
(28 with IPD and 28 healthy children)
IPD group:
20.8–60.2 months (median 43 m)
Control group:
31.6–58.9 (median 42.6 m)
BreastfeedingDolosigranulum dominated profiles appeared to be more resistant to pneumococcal infection occurrence and severity
A higher proportion of Dolosigranulum dominated profiles was identified in healthy controls that were breastfed
A significant negative correlation was observed between Dolosigranulum vs. Streptococcus (p = 0.029)
Non-diphtheriae Corynebacterium species are associated with decreased risk of pneumococcal colonization during infancy
(2021)
[44]
Longitudinal URT microbiota analysis
in mother-infants dyads
179 mother–infant dyads
(1368
infant and 172 maternal samples)
<1 year
(NP swabs collected monthly between 0–6 months of age and bimonthly between 6–12 months)
Breastfeeding
Season
Strong negative association between the relative abundance of Corynebacterium and S. pneumoniae colonization rate
Breastfeeding was associated with an increase in Corynebacterium relative abundance
Antibiotic exposures and the winter season related to a decline in the relative abundance of Corynebacterium
Differential nasopharyngeal microbiota composition in children according to respiratory health status
(2021)
[45]
Prospective case–control study.
NP microbiota analysis in three groups of children: cases with IPD, symptomatic controls with mild viral URTI, and health controls
140
(IPD = 27; URTI = 48; healthy = 65).
IPD: 19.0–49.5 m (median 33 m)
URTI: 14.7–45.0 m (median 24.5 m)
Healthy controls: 19.0–43.0 m (median 31 m)
BreastfeedingIPD group was characterized by a higher representation of S. pneumoniae and a reduced abundance of Dolosigranulum and Moraxella lincolnii
A longer duration of breastfeeding seemed to influence the microbiota structure; however, the authors did not evidence a significant enrichment in beneficial bacteria in children breastfed for at least 6 months
The Influence of FUT2 and FUT3 Polymorphisms and Nasopharyngeal Microbiome on Respiratory Infections in Breastfed Bangladeshi Infants from the Microbiota and Health Study (2021)
[48]
Longitudinal URT microbiota analysis through shotgun metagenomics in a cohort of breastfed infants and the potential influence of fucosylated human milk oligosaccharides (HMOs) on its composition and ARI incidence in the first two years of life240 children
(422 total samples)
<2 yBreastfeeding
Season
Maternal secretor status was associated with reduced ARI incidence from birth to 6 months
HMOs could act through an immunomodulatory effect, rather than through an impact on microbiota composition
Season at sampling was the most relevant environmental factor shaping the microbial communities
Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery
(2016)
[59]
Longitudinal NP microbiota analysis in the first 6 months of life; comparison between URT microbiota in vaginally delivered children with those born by CS102
(Vaginal delivery = 62; CS = 40)
761 total samples
<6 mDelivery routeNiche differentiation occurs in the first week of life, initially with Staphylococcus aureus predominance, followed by differentiation towards Corynebacterium pseudodiphteriticum/propinquum, Dolosigranulum pigrum, Moraxella catarrhalis/nonliquefaciens, Streptococcus pneumoniae, and/or Haemophilus influenzae dominated communities
Delay in microbiota development and reduced abundance of Corynebacterium and Dolosigranulum in infants born by CS
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
(2010)
[60]
Characterization of bacterial communities from mothers and newborn babies in different body sites (mothers’ skin, oral mucosa, and vagina; neonates’ skin, oral mucosa, URT, and meconium)10
(4 born vaginally, 6 born by CS)
Neonates (samples collected in the first hours of life)Delivery routeVaginally delivered infants acquire bacterial communities similar to their mother’s vaginal microbiota (Lactobacillus, Prevotella, Sneathia spp.)
CS delivered infants harbored bacterial communities similar to those found on the skin surface (Staphylococcus, Corynebacterium, and Propionibacterium spp.)
Nasopharyngeal microbiome analyses in otitis-prone and otitis-free children (2021)
[72]
Comparison of URT microbiota in sOP and otitis-free children at 6 and 12 months of age 28 sOP children
68 AOM-free children
(157 total samples)
<1 y
(samples collected at 6 and 12 months of age)
Daycare attendanceA different global microbiome profile was observed in the NP microbiome of sOP children when 6 months old
Bacillus, Prevotella, Gemella, Veillonella, and Actinomyces were less abundant in sOP samples
The two most important factors associated with these differences were S. pneumoniae colonization and daycare attendance
Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis
(2011)
[80]
NP microbiota analysis in healthy children; comparison of microbial composition between children sampled in winter/fall with children sampled in spring96 healthy childrenAll samples collected at 18 m of ageSeasonWinter samples were characterized by a higher relative abundance of Proteobacteria (75% versus 51% in spring) and Fusobacteria (14% versus 2% in spring); spring samples had a higher abundance of Bacteroidetes (relative abundance: 19% versus 3% in fall/winter), and Firmicutes
Dynamics of the nasal microbiota in infancy: A prospective cohort study
(2015)
[81]
Longitudinal URT microbiota analysis in unselected infants in the first year of life47 unselected infants
(872 total samples collected biweekly)
<1 ySeasonRelative abundance and microbiota composition differed significantly according to season, as Corynebacteriaceae were more abundant in summer months, while Pasteurellacee were more abundant during winter
Season of Birth Impacts the Neonatal Nasopharyngeal Microbiota
(2020)
[82]
Analysis of neonatal URT microbiota and its relation with perinatal risk factors328 samples 1 mSeasonEarly NP microbiota is significantly affected by birth season

Gram-negative alpha-proteobacteria and Gram-positive Bacilli were more abundant in the nasopharynx of summer-born children
Household siblings and nasal and fecal microbiota in infants
(2017)
[89]
Cross-sectional analysis of nasal and fecal microbiota and its relation with siblings105 healthy children<1 y
(median age 3.4 m)
SiblingsInfants with siblings were more likely to have a Moraxella dominated profile than Corynebacterium/Dolosigranulum dominated profile (76% vs. 18%)
Establishment of the nasal microbiota in the first 18 months of life: Correlation with early-onset rhinitis and wheezing
(2018)
[90]
Longitudinal nasal microbiota analysis of infants with rhinitis and wheeze in the first 18 months of life and healthy controls 122 children divided in 3 groups: patients with rhinitis alone (n = 28), patients with rhinitis and concomitant wheeze (n = 34), healthy controls (n = 60)<18 mSiblings
Daycare attendance
Delivery route
Control group showed a higher abundance of Corynebacteriaceae and early colonization with Staphylococcaceae
Determinants of nasal microbiota succession included sex, mode of delivery, presence of siblings, daycare attendance
Associations of air pollution and greenness with the nasal microbiota of healthy infants: A longitudinal study (2021)
[95]
Longitudinal study investigating the association of greenness and air pollution with the nasal microbiota in the first year of life47 healthy infants
846 swabs collected
<1 yearPollutionDistinct microbiota profiles for different PM2.5 exposure levels.
Increased NO2 was associated with reduced abundance of Corynebacteriaceae
NP: Nasopharyngeal; URT: Upper respiratory tract; RTI: Respiratory tract infection; IPD: Invasive pneumococcal disease; URTI: Upper respiratory tract infection; ARI: Acute respiratory infection; CS: Caesarian section; sOP: Stringently defined otitis prone; AOM: Acute otitis media.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Folino, F.; Bosi, P.; Torretta, S.; Gaffuri, M.; Marchisio, P. Recurrent Acute Otitis Media Environmental Risk Factors: A Literature Review from the Microbiota Point of View. Appl. Microbiol. 2022, 2, 594-613. https://doi.org/10.3390/applmicrobiol2030046

AMA Style

Folino F, Bosi P, Torretta S, Gaffuri M, Marchisio P. Recurrent Acute Otitis Media Environmental Risk Factors: A Literature Review from the Microbiota Point of View. Applied Microbiology. 2022; 2(3):594-613. https://doi.org/10.3390/applmicrobiol2030046

Chicago/Turabian Style

Folino, Francesco, Pietro Bosi, Sara Torretta, Michele Gaffuri, and Paola Marchisio. 2022. "Recurrent Acute Otitis Media Environmental Risk Factors: A Literature Review from the Microbiota Point of View" Applied Microbiology 2, no. 3: 594-613. https://doi.org/10.3390/applmicrobiol2030046

Article Metrics

Back to TopTop